Dehydroepiandrosterone (DHEA) supplementation and IVF outcome in poor responders

References

• Arlt, W., Justl, H.G., Callies, F., Reincke, M., Hubler, D., Oettel, M., … Allolio, B. (1998). Oral dehydroepiandrosterone for adrenal androgen replacement: Pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. Journal of Clinical Endocrinology and Metabolism, 83, 1928–1934. doi:10.1210/jcem.83.6.4850.
   PubMed Web of Science ®Google Scholar
• Barad, D., Brill, H., & Gleicher, N. (2007). Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function. Journal of Assisted Reproduction and Genetics, 24, 629–634. doi:10.1007/s10815-007-9178-x.
   PubMed Web of Science ®Google Scholar
• Barad, D., & Gleicher, N. (2006). Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF. Human Reproduction, 21, 2845–2849. doi:10.1093/humrep/del254.
   PubMed Web of Science ®Google Scholar
• Barad, D.H., & Gleicher, N. (2005). Increased oocyte production after treatment with dehydroepiandrosterone. Fertility and Sterility, 84, 756–756.e3. https://doi.org/http://dx.doi.org/10.1016/j.fertnstert.2005.02.049.
   PubMed Web of Science ®Google Scholar
• Belgorosky, D., Sander, V.A., Yorio, M.P., Faletti, A.G., & Motta, A.B. (2010). Hyperandrogenism alters intraovarian parameters during early folliculogenesis in mice. Reproductive Biomedicine Online, 20, 797–807. https://doi.org/http://dx.doi.org/10.1016/j.rbmo.2010.02.012.
   PubMed Web of Science ®Google Scholar
• Bettio, D., Venci, A., & Levi Setti, P.E. (2008). Chromosomal abnormalities in miscarriages after different assisted reproduction procedures. Placenta, 29, 126–128. doi:10.1016/j.placenta.2008.08.015.
   PubMed Web of Science ®Google Scholar
• Borman, E., Check, J.H., Wilson, C., & Cohen, R. (2010). No evidence to support the concept that low serum dehydroepiandrosterone (DHEA) sulfate (S) levels are associated with less oocyte production or lower pregnancy rates. Fertility and Sterility, 94, S161. https://doi.org/http://dx.doi.org/10.1016/j.fertnstert.2010.07.641.
   Web of Science ®Google Scholar
• Broekmans, F.J., Kwee, J., Hendriks, D.J., Mol, B.W., & Lambalk, C.B. (2006). A systematic review of tests predicting ovarian reserve and IVF outcome. Human Reproduction Update, 12, 685–718. doi:10.1093/humupd/dml034.
   PubMed Web of Science ®Google Scholar
• Casson, P.R., Lindsay, M.S., Pisarska, M.D., Carson, S.A., & Buster, J.E. (2000). Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: A case series. Human Reproduction, 15, 2129–2132. doi:10.1093/humrep/15.10.2129.
   PubMed Web of Science ®Google Scholar
• Casson, P.R., Santoro, N., Elkind-Hirsch, K., Carson, S.A., Hornsby, P.J., Abraham, G., & Buster, J.E. (1998). Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: A six-month trial. Fertility and Sterility, 70, 107–110. https://doi.org/http://dx.doi.org/10.1016/S0015-0282(98)00121-6.
   PubMed Web of Science ®Google Scholar
• Corpechot, C., Robel, P., Axelson, M., Sjovall, J., & Baulieu, E.E. (1981). Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proceedings of the National Academy of Sciences of the United States of America, 78, 4704–4707. doi:10.1073/pnas.78.8.4704.
   PubMed Web of Science ®Google Scholar
• Dorrington, J.H., Moon, Y.S., & Armstrong, D.T. (1975). Estradiol-17beta biosynthesis in cultured granulosa cells from hypophysectomized immature rats; stimulation by follicle-stimulating hormone. Endocrinology, 97, 1328–1331. doi:10.1210/endo-97-5-1328.
   PubMed Web of Science ®Google Scholar
• Ferraretti, A.P., La Marca, A., Fauser, B.C., Tarlatzis, B., Nargund, G., & Gianaroli, L. (2011). ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: The Bologna criteria. Human Reproduction, 26, 1616–1624. doi:10.1093/humrep/der092.
   PubMed Web of Science ®Google Scholar
• Fouany, M.R., & Sharara, F.I. (2013). Is there a role for DHEA supplementation in women with diminished ovarian reserve? Journal of Assisted Reproduction and Genetics, 30, 1239–1244. doi:10.1007/s10815-013-0018-x.
   PubMed Web of Science ®Google Scholar
• Gleicher, N., & Barad, D.H. (2011). Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR). Reproductive Biology and Endocrinology, 9, 67. doi:10.1186/1477-7827-9-67.
   PubMed Web of Science ®Google Scholar
• Gleicher, N., Ryan, E., Weghofer, A., Blanco-Mejia, S., & Barad, D.H. (2009). Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: A case control study. Reproductive Biology and Endocrinology, 7, 108. doi:10.1186/1477-7827-7-108.
   PubMed Web of Science ®Google Scholar
• Gleicher, N., Weghofer, A., & Barad, D.H. (2010a). Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: Direct evidence from preimplantation genetic screening (PGS). Reproductive Biology and Endocrinology, 8, 140. doi:10.1186/1477-7827-8-140.
   PubMed Web of Science ®Google Scholar
• Gleicher, N., Weghofer, A., & Barad, D.H. (2010b). Improvement in diminished ovarian reserve after dehydroepiandrosterone supplementation. Reproductive Biomedicine Online, 21, 360–365. https://doi.org/http://dx.doi.org/10.1016/j.rbmo.2010.04.006.
   PubMed Web of Science ®Google Scholar
• Haning, R.V., Jr., Hackett, R.J., Flood, C.A., Loughlin, J.S., Zhao, Q.Y., & Longcope, C. (1993). Plasma dehydroepiandrosterone sulfate serves as a prehormone for 48% of follicular fluid testosterone during treatment with menotropins. Journal of Clinical Endocrinology & Metabolism, 76, 1301–1307. doi:10.1210/jcem.76.5.8496321.
   PubMed Web of Science ®Google Scholar
• Harlow, C.R., Hillier, S.G., & Hodges, J.K. (1986). Androgen modulation of follicle-stimulating hormone-induced granulosa cell steroidogenesis in the primate ovary. Endocrinology, 119, 1403–1405. doi:10.1210/endo-119-3-1403.
   PubMed Web of Science ®Google Scholar
• Hillier, S.G. (1985). Sex steroid metabolism and follicular development in the ovary. Oxford Reviews of Reproductive Biology, 7, 168–222. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/3001616
   PubMedGoogle Scholar
• Hillier, S.G., Whitelaw, P.F., & Smyth, C.D. (1994). Follicular oestrogen synthesis: The ‘two-cell, two-gonadotrophin’ model revisited. Molecular and Cellular Endocrinology, 100, 51–54. https://doi.org/http://dx.doi.org/10.1016/0303-7207(94)90278-X.
   PubMed Web of Science ®Google Scholar
• Hyman, J.H., Margalioth, E.J., Rabinowitz, R., Tsafrir, A., Gal, M., Alerhand, S., … Eldar-Geva, T. (2013). DHEA supplementation may improve IVF outcome in poor responders: A proposed mechanism. European Journal of Obstetrics and Gynecology, 168, 49–53. https://doi.org/http://dx.doi.org/10.1016/j.ejogrb.2012.12.017.
   PubMed Web of Science ®Google Scholar
• IVF Worldwide Survey. (2012). Poor responders: How to define, diagnose and treat? Retrieved from www.IVF-Worldwide.com
   Google Scholar
• Jirge, P.R., Chougule, S.M., Gavali, V.G., & Bhomkar, D.A. (2014). Impact of dehydroepiandrosterone on clinical outcome in poor responders: A pilot study in women undergoing in vitro fertilization, using bologna criteria. Journal of Human Reproductive Sciences, 7, 175–180. doi:10.4103/0974-1208.142477.
   PubMedGoogle Scholar
• Kara, M., Aydin, T., Aran, T., Turktekin, N., & Ozdemir, B. (2014). Does dehydroepiandrosterone supplementation really affect IVF-ICSI outcome in women with poor ovarian reserve? European Journal of Obstetrics and Gynecology and Reproductive Biology, 173, 63–65. https://doi.org/http://dx.doi.org/10.1016/j.ejogrb.2013.11.008.
   PubMed Web of Science ®Google Scholar
• Kolibianakis, E.M., Venetis, C.A., Diedrich, K., Tarlatzis, B.C., & Griesinger, G. (2009). Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: A systematic review and meta-analysis. Human Reproduction Update, 15, 613–622. 10.1093/humupd/dmp026.
   PubMed Web of Science ®Google Scholar
• Kolibianakis, E.M., Venetis, C.A., & Tarlatzis, B.C. (2011). DHEA administration in poor responders. Human Reproduction, 26, 730–731. author reply 731. doi:10.1093/humrep/deq397.
   PubMed Web of Science ®Google Scholar
• Kotb, M.M., Hassan, A.M., & Awadallah, A.M. (2016). Does dehydroepiandrosterone improve pregnancy rate in women undergoing IVF/ICSI with expected poor ovarian response according to the Bologna criteria? A randomized controlled trial. European Journal of Obstetrics and Gynecology and Reproductive Biology, 200, 11–15. https://doi.org/http://dx.doi.org/10.1016/j.ejogrb.2016.02.009.
   PubMed Web of Science ®Google Scholar
• Labrie, F., Belanger, A., Cusan, L., Gomez, J.L., & Candas, B. (1997). Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. Journal of Clinical Endocrinology & Metabolism, 82, 2396–2402. doi:10.1210/jcem.82.8.4160.
   PubMed Web of Science ®Google Scholar
• Lee, M.T., Anderson, E., & Lee, G.Y. (1991). Changes in ovarian morphology and serum hormones in the rat after treatment with dehydroepiandrosterone. The Anatomical Record, 231, 185–192. doi:10.1002/ar.1092310206.
   PubMedGoogle Scholar
• Li, J., Yuan, H., Chen, Y., Wu, H., Wu, H., & Li, L. (2015). A meta-analysis of dehydroepiandrosterone supplementation among women with diminished ovarian reserve undergoing in vitro fertilization or intracytoplasmic sperm injection. International Journal of Gynecology & Obstetrics, 131, 240–245. https://doi.org/http://dx.doi.org/10.1016/j.ijgo.2015.06.028.
   PubMed Web of Science ®Google Scholar
• Madani, T., Ashrafi, M., & Yeganeh, L.M. (2012). Comparison of different stimulation protocols efficacy in poor responders undergoing IVF: A retrospective study. Gynecological Endocrinology, 28, 102–105. https://doi.org/http://dx.doi.org/10.3109/09513590.2011.579206.
   PubMed Web of Science ®Google Scholar
• Mamas, L., & Mamas, E. (2009a). Dehydroepiandrosterone supplementation in assisted reproduction: Rationale and results. Current Opinion in Obstetrics and Gynecology, 21, 306–308. doi:10.1097/GCO.0b013e32832e0785.
   PubMed Web of Science ®Google Scholar
• Mamas, L., & Mamas, E. (2009b). Premature ovarian failure and dehydroepiandrosterone. Fertility and Sterility, 91, 644–646. https://doi.org/http://dx.doi.org/10.1016/j.fertnstert.2007.11.055.
   PubMed Web of Science ®Google Scholar
• Morales, A.J., Nolan, J.J., Nelson, J.C., & Yen, S.S. (1994). Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. Journal of Clinical Endocrinology & Metabolism, 78, 1360–1367. doi:10.1210/jcem.78.6.7515387.
   PubMed Web of Science ®Google Scholar
• Motta, E.L., Rossi, L.M., Fernandes, T.R., Massaguer, A.A., Fassolas, G., & Serafini, P. (2006). The use DHEA in poor responders does not improve IVF outcomes: Insights of a pilot study. Fertility and Sterility, 86, S428. https://doi.org/http://dx.doi.org/10.1016/j.fertnstert.2006.07.1183.
   Web of Science ®Google Scholar
• Pandian, Z., Mctavish, A.R., Aucott, L., Hamilton, M.P., & Bhattacharya, S. (2010). Interventions for ‘poor responders’ to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF). Cochrane Database of Systematic Reviews, (1), CD004379. doi:10.1002/14651858.CD004379.pub3.
   Google Scholar
• Polyzos, N.P., & Devroey, P. (2011). A systematic review of randomized trials for the treatment of poor ovarian responders: Is there any light at the end of the tunnel? Fertility and Sterility, 96, 1058–1061 e7. https://doi.org/http://dx.doi.org/10.1016/j.fertnstert.2011.09.048.
   PubMed Web of Science ®Google Scholar
• Sönmezer, M., Özmen, B., Çil, A.P., Özkavukçu, S., Taşçi, T., Olmuş, H., & Atabekoğlu, C.S. (2009). Dehydroepiandrosterone supplementation improves ovarian response and cycle outcome in poor responders. Reproductive Biomedicine Online, 19, 508–513. https://doi.org/http://dx.doi.org/10.1016/j.rbmo.2009.06.006.
   PubMed Web of Science ®Google Scholar
• Sunkara, S.K., Coomarasamy, A., Arlt, W., & Bhattacharya, S. (2012). Should androgen supplementation be used for poor ovarian response in IVF? Human Reproduction, 27, 637–640. http://dx.doi.org/10.1093/humrep/der464.
   PubMed Web of Science ®Google Scholar
• Surrey, E.S., & Schoolcraft, W.B. (2000). Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertility and Sterility, 73, 667–676. https://doi.org/http://dx.doi.org/10.1016/S0015-0282(99)00630-5.
   PubMed Web of Science ®Google Scholar
• Tartagni, M., Cicinelli, M.V., Baldini, D., Tartagni, M.V., Alrasheed, H., Desalvia, M.A., … Montagnani, M. (2015). Dehydroepiandrosterone decreases the age-related decline of the in vitro fertilization outcome in women younger than 40 years old. Reproductive Biology and Endocrinology, 13, 18. doi:10.1186/s12958-015-0014-3.
   PubMed Web of Science ®Google Scholar
• Van Weering, H.G., Gutknecht, D.R., & Schats, R. (2001). Augmentation of ovarian response by dehydroepiandrosterone. Human Reproduction, 16, 1537–1538. doi:10.1093/humrep/16.7.1537-b.
   PubMed Web of Science ®Google Scholar
• Vendola, K., Zhou, J., Wang, J., Famuyiwa, O.A., Bievre, M., & Bondy, C.A. (1999). Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary. Biology of Reproduction, 61, 353–357. doi:10.1095/biolreprod61.2.353.
   PubMed Web of Science ®Google Scholar
• Vendola, K.A., Zhou, J., Adesanya, O.O., Weil, S.J., & Bondy, C.A. (1998). Androgens stimulate early stages of follicular growth in the primate ovary. Journal of Clinical Investigation, 101, 2622–2629. doi:10.1172/JCI2081.
   PubMed Web of Science ®Google Scholar
• Vlahos, N., Papalouka, M., Triantafyllidou, O., Vlachos, A., Vakas, P., Grimbizis, G., … Zikopoulos, K. (2015). Dehydroepiandrosterone administration before IVF in poor responders: A prospective cohort study. Reproductive Biomedicine Online, 30, 191–196. https://doi.org/http://dx.doi.org/10.1016/j.rbmo.2014.10.005.
   PubMed Web of Science ®Google Scholar
• Vollenhoven, B., Osianlis, T., & Catt, J. (2008). Is there an ideal stimulation regimen for IVF for poor responders and does it change with age? Journal of Assisted Reproduction and Genetics, 25, 523–529. doi:10.1007/s10815-008-9274-6.
   PubMed Web of Science ®Google Scholar
• Weil, S., Vendola, K., Zhou, J., & Bondy, C.A. (1999). Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. Journal of Clinical Endocrinology & Metabolism, 84, 2951–2956. doi:10.1210/jcem.84.8.5929.
   PubMed Web of Science ®Google Scholar
• Wiser, A., Gonen, O., Ghetler, Y., Shavit, T., Berkovitz, A., & Shulman, A. (2010). Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: A randomized prospective study. Human Reproduction, 25, 2496–2500. doi:10.1093/humrep/deq220.
   PubMed Web of Science ®Google Scholar
• Xu, B., Li, Z., Yue, J., Jin, L., Li, Y., Ai, J., … Zhu, G. (2014). Effect of dehydroepiandrosterone administration in patients with poor ovarian response according to the Bologna criteria. PLoS One, 9, e99858. https://doi.org/http://dx.doi.org/10.1371/journal.pone.0099858.
   PubMed Web of Science ®Google Scholar
• Yakin, K., & Urman, B. (2011). DHEA as a miracle drug in the treatment of poor responders; hype or hope? Human Reproduction, 26, 1941–1944. doi:10.1093/humrep/der150.
   PubMed Web of Science ®Google Scholar
• Yeung, T.W., Chai, J., Li, R.H., Lee, V.C., Ho, P.C., & Ng, E.H. (2014). A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization outcomes in poor responders. Fertility and Sterility, 102, 108–115. e1. https://doi.org/http://dx.doi.org/10.1016/j.fertnstert.2014.03.044.
   PubMed Web of Science ®Google Scholar
• Yeung, T.W., Li, R.H., Lee, V.C., Ho, P.C., & Ng, E.H. (2013). A randomized double-blinded placebo-controlled trial on the effect of dehydroepiandrosterone for 16 weeks on ovarian response markers in women with primary ovarian insufficiency. Journal of Clinical Endocrinology & Metabolism, 98, 380–388. doi:10.1210/jc.2012-3071.
   PubMed Web of Science ®Google Scholar
• Yilmaz, N., Uygur, D., Inal, H., Gorkem, U., Cicek, N., & Mollamahmutoglu, L. (2013). Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: Serum AMH, inhibin B and antral follicle count. European Journal of Obstetrics and Gynecology and Reproductive Biology, 169, 257–260. https://doi.org/http://dx.doi.org/10.1016/j.ejogrb.2013.04.003.
   PubMed Web of Science ®Google Scholar